Search
for
Sort by
Research 451–480 of 1000+
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Viable terminal scalp hair follicles constitute a necessary and sufficient biological end‐organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles
- Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
- Male Pattern Androgenetic Alopecia
- Follow-Up of 1 mg Finasteride Treatment of Male Pattern Baldness-Difference between Clinical Trials and Private Office Follow-Up: Influences on Prescribing Habits Evaluated
- Male-Pattern Baldness Is Common in Men with X-Linked Recessive Ichthyosis
- Animal models for male pattern (androgenetic) alopecia.
- Male pattern hair loss: prevention rather than regrowth
- Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double‐blind, placebo‐controlled, phase 1B clinical trial
- Therapeutic implications of topical cetirizine 1% in treatment of male androgenetic alopecia: A case‐controlled study
- Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia
- Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol
- Dermoscopic assessment of microneedling alone versus microneedling with platelet-rich plasma in cases of male pattern alopecia: A split-head comparative study
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America
- Genetic Prediction of Male Pattern Baldness
- Male androgenetic alopecia treated with microneedling alone or associated with injectable minoxidil by microinfusion of drugs into the skin
- Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia
- The Adapted Classification of Male Pattern Hair Loss Improves Reliability
- Predictors of Future Anxiety about Male Pattern Baldness in New Zealand Males
- Validation of scalp coverage scoring methods for scalp hair loss in male pattern hair loss (androgenetic alopecia)
- Minoxidil and male-pattern alopecia: a potential role for a local regulator of sebum secretion with vasoconstrictive effects?
- Reproducibility of global photographic assessments of patients with male pattern baldness in a clinical trial with finasteride.
- Genetic correlation analysis does not associate male pattern baldness with COVID-19
- Autologous Concentrated Growth Factors Combined with Topical Minoxidil for the Treatment of Male Androgenetic Alopecia: A Randomized Controlled Clinical Trial
- Serum 25 hydroxyvitamin D levels in alopecia areata, female pattern hair loss, and male androgenetic alopecia in a Chinese population
- Severity of androgenetic alopecia associated with poor sleeping habits and carnivorous eating and junk food consumption—A web‐based investigation of male pattern hair loss in China
- Maintenance of optimised hair growth from viable terminal scalp hair follicles at baseline with oral finasteride in male pattern hair loss and first evidence of a “drug dependency” and a post-finasteride “rebound effect”.
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction